The PDGF/PDGFR pathway as a drug target

N Papadopoulos, J Lennartsson - Molecular aspects of medicine, 2018 - Elsevier
Platelet-derived growth factors (PDGF) promotes cell proliferation, survival and migration,
primarily of cells of mesenchymal origin. Dysfunction of PDGF signaling has been observed …

Evolving therapies for liver fibrosis

D Schuppan, YO Kim - The Journal of clinical investigation, 2013 - Am Soc Clin Investig
Fibrosis is an intrinsic response to chronic injury, maintaining organ integrity when extensive
necrosis or apoptosis occurs. With protracted damage, fibrosis can progress toward …

PDGF in organ fibrosis

BM Klinkhammer, J Floege, P Boor - Molecular Aspects of Medicine, 2018 - Elsevier
Fibrosis is part of a tissue repair response to injury, defined as increased deposition of
extracellular matrix. In some instances, fibrosis is beneficial; however, in the majority of …

[HTML][HTML] TGF-β and fibrosis in different organs—molecular pathway imprints

D Pohlers, J Brenmoehl, I Löffler, CK Müller… - … et Biophysica Acta (BBA …, 2009 - Elsevier
The action of transforming-growth-factor (TGF)-β following inflammatory responses is
characterized by increased production of extracellular matrix (ECM) components, as well as …

Expression of MMPs and TIMPs in liver fibrosis–a systematic review with special emphasis on anti-fibrotic strategies

S Hemmann, J Graf, M Roderfeld, E Roeb - Journal of hepatology, 2007 - Elsevier
In liver tissue matrix metalloproteinases (MMPs) and their specific inhibitors (tissue inhibitors
of metalloproteinases, TIMPs) play a pivotal role in both, fibrogenesis and fibrolysis. The …

Management strategies for liver fibrosis

A Altamirano-Barrera, B Barranco-Fragoso… - Annals of …, 2017 - medigraphic.com
Liver fibrosis resulting from chronic liver injury are major causes of morbidity and mortality
worldwide. Among causes of hepatic fibrosis, viral infection is most common (hepatitis B and …

The PDGF system and its antagonists in liver fibrosis

E Borkham-Kamphorst, R Weiskirchen - Cytokine & growth factor reviews, 2016 - Elsevier
Platelet derived growth factor (PDGF) signaling plays an important role in activated hepatic
stellate cells and portal fibroblast proliferation, chemotaxis, migration and cell survival …

[HTML][HTML] Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?

D Thabut, V Shah - Journal of hepatology, 2010 - Elsevier
Portal hypertension accounts for the majority of morbidity and mortality that is encountered in
patients with cirrhosis. Portal hypertension is initiated in large part through increases in …

microRNA-21, via the HIF-1α/VEGF signaling pathway, is involved in arsenite-induced hepatic fibrosis through aberrant cross-talk of hepatocytes and hepatic stellate …

J Sun, L Shi, T Xiao, J Xue, J Li, P Wang, L Wu, X Dai… - Chemosphere, 2021 - Elsevier
Long-term exposure to arsenic, a widely distributed environmental toxicant, may result in
damage to various organs, including the liver. Mice exposed chronically to arsenite …

Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice

S Yoshida, N Ikenaga, SB Liu, ZW Peng, J Chung… - Gastroenterology, 2014 - Elsevier
Background & Aims Platelet-derived growth factor-β (PDGFB) is a mitogen for hepatic
stellate cells (HSCs). We studied the cellular sources of PDGFB and the effects of a high …